Latest Intellectual Property News

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

EcoGraf Limited has advanced its vertically integrated battery anode materials business with a US$105 million loan mandate for the Epanko Graphite Mine, expanded mining licences, and progress in purification technology and community initiatives.

Holista Colltech has closed its ASIC penalty chapter with a $900K final payment, raised $1.53 million through convertible notes, and reported a 10.9% year-on-year sales increase driven by its Dietary Supplements division.

Magnetite Mines has submitted a key Mining Lease Proposal for its Razorback Iron Ore Project and is progressing strategic funding agreements, including a $7 million convertible note facility. The company also filed a provisional patent for a novel saline water processing method, underscoring its technical innovation in green iron production.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Immutep Limited has dosed the first patient in its pivotal Phase III lung cancer trial and completed enrolments in multiple studies, supported by a robust cash position expected to fund operations through 2026.

Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.

Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.

Everest Metals Corporation has launched a major aircore drilling campaign at its Revere Gold Project while advancing a pioneering rubidium extraction patent at Mt Edon, setting the stage for resource growth and near-term mining at Mt Dimer.

Prime Financial Group has agreed to acquire Lincoln Indicators, a leading Australian investment research and funds management firm, significantly boosting its wealth management capabilities and client base.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.